NanoView Biosciences, Inc.

Biotechnology company · Boston, Massachusetts, United States

NanoView Biosciences, Inc. is a biotechnology company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2015. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $578,923 in total, most recently in 2021. It has reported private securities offerings to the US SEC, most recently $2.5 million sold in a notice filed in 2022.

Profile compiled from public records. Is this your company? Request a correction or update

NanoView Biosciences at a glance

Typebiotechnology company
HeadquartersBoston, Massachusetts, United States
Earliest incorporation on record2015
Employees (self-reported, 2021)21
SEC CIK1754605

What does NanoView Biosciences do?

US government research funding

2 SBIR/STTR small-business research awards from US health agencies, $578,923 in total (2017 to 2021). NIH funding came from the National Cancer Institute.

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $2.5 million sold (2022).

Frequently asked questions about NanoView Biosciences

Where is NanoView Biosciences headquartered?

NanoView Biosciences, Inc. is headquartered in Boston, Massachusetts, United States.

What does NanoView Biosciences do?

NanoView Biosciences, Inc. is a biotechnology company.

When was NanoView Biosciences founded?

The earliest incorporation on record for NanoView Biosciences, Inc. is in 2015, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences